Evidence map›Paper›PMID 39643744›Full record

ReviewDermatologie (Heidelberg, Germany)2025

[Bacterial cutaneous infections in diabetes mellitus and treatment].

Evgenia Makrantonaki, Spyridon Kostaras, Christos C Zouboulis

Abstract readEnglish AbstractReview
PubMed Publisher
In one paragraph

Review in Dermatologie (Heidelberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Skin microbiota and diabetic foot ulcers.Frontiers in microbiology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Evgenia MakrantonakiAbteilungen für Dermatologie, Venerologie, Allergologie und Immunologie, Dessau Medical Center, Brandenburg Medizinische Hochschule Theodor Fontane, Auenweg 38, 06847, Dessau, Deutschland. emakrantonaki@yahoo.com.
Spyridon KostarasDerma Zentrum Wildeshausen, Westerstr. 46-48, 27793, Wildeshausen, Deutschland.
Christos C ZouboulisAbteilungen für Dermatologie, Venerologie, Allergologie und Immunologie, Dessau Medical Center, Brandenburg Medizinische Hochschule Theodor Fontane, Auenweg 38, 06847, Dessau, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes mellitus (DM) is a debilitating, life-limiting disease. According to recent estimates, 415 million adults currently suffer from the disease. This number is expected to rise to 642 million by 2040. Skin disorders can often predict the onset of this metabolic disorder. Uncontrolled hyperglycemia impairs the overall immunity of patients with DM, involving various mechanistic pathways, resulting in the diabetic skin being immunocompromised and prone to bacterial infections. Among others, diabetic foot infections are very common. In this article, we have focused on the association of DM with different types of bacterial skin infections and resistance patterns to antimicrobial agents commonly used in the treatment of diabetes-associated infections.

Indexed as

Anti-Bacterial AgentsSkin Diseases, BacterialDiabetes ComplicationsDiabetic FootHumansAnti-Bacterial AgentsAdaptive immunityClinical presentationInnate immunityPathogenesisSkin diseases

Identifiers

PMID39643744

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.